STEREOTAXIS INC (STXS) Fundamental Analysis & Valuation

NYSEARCA:STXS • US85916J4094

Current stock price

1.82 USD
-0.07 (-3.7%)
At close:
1.82 USD
0 (0%)
After Hours:

This STXS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. STXS Profitability Analysis

1.1 Basic Checks

  • In the past year STXS has reported negative net income.
  • STXS had a negative operating cash flow in the past year.
  • STXS had negative earnings in each of the past 5 years.
  • STXS had a negative operating cash flow in each of the past 5 years.
STXS Yearly Net Income VS EBIT VS OCF VS FCFSTXS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M -25M

1.2 Ratios

  • STXS has a Return On Assets of -43.86%. This is in the lower half of the industry: STXS underperforms 64.55% of its industry peers.
  • STXS's Return On Equity of -122.40% is on the low side compared to the rest of the industry. STXS is outperformed by 67.20% of its industry peers.
Industry RankSector Rank
ROA -43.86%
ROE -122.4%
ROIC N/A
ROA(3y)-50.25%
ROA(5y)-41.46%
ROE(3y)-148.26%
ROE(5y)-107.38%
ROIC(3y)N/A
ROIC(5y)N/A
STXS Yearly ROA, ROE, ROICSTXS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

1.3 Margins

  • Looking at the Gross Margin, with a value of 52.73%, STXS is in line with its industry, outperforming 50.26% of the companies in the same industry.
  • In the last couple of years the Gross Margin of STXS has declined.
  • STXS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.03%
GM growth 5Y-5.84%
STXS Yearly Profit, Operating, Gross MarginsSTXS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. STXS Health Analysis

2.1 Basic Checks

  • STXS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for STXS has been increased compared to 1 year ago.
  • Compared to 5 years ago, STXS has more shares outstanding
  • STXS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
STXS Yearly Shares OutstandingSTXS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
STXS Yearly Total Debt VS Total AssetsSTXS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • STXS has an Altman-Z score of -12.75. This is a bad value and indicates that STXS is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -12.75, STXS is not doing good in the industry: 82.54% of the companies in the same industry are doing better.
  • STXS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -12.75
ROIC/WACCN/A
WACC10.63%
STXS Yearly LT Debt VS Equity VS FCFSTXS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

2.3 Liquidity

  • STXS has a Current Ratio of 1.51. This is a normal value and indicates that STXS is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of STXS (1.51) is worse than 74.07% of its industry peers.
  • A Quick Ratio of 1.09 indicates that STXS should not have too much problems paying its short term obligations.
  • The Quick ratio of STXS (1.09) is worse than 73.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.09
STXS Yearly Current Assets VS Current LiabilitesSTXS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. STXS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 16.67% over the past year.
  • The Revenue has grown by 20.28% in the past year. This is a very strong growth!
  • Measured over the past years, STXS shows a small growth in Revenue. The Revenue has been growing by 3.99% on average per year.
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)20.28%
Revenue growth 3Y4.77%
Revenue growth 5Y3.99%
Sales Q2Q%36.31%

3.2 Future

  • Based on estimates for the next years, STXS will show a very strong growth in Earnings Per Share. The EPS will grow by 25.04% on average per year.
  • Based on estimates for the next years, STXS will show a very strong growth in Revenue. The Revenue will grow by 32.48% on average per year.
EPS Next Y22.81%
EPS Next 2Y25.04%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year29.83%
Revenue Next 2Y32.48%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
STXS Yearly Revenue VS EstimatesSTXS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
STXS Yearly EPS VS EstimatesSTXS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 -0.05 -0.1 -0.15 -0.2 -0.25

More info and screens

Find the best growth stocksShow best growing peers

1

4. STXS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for STXS. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for STXS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STXS Price Earnings VS Forward Price EarningsSTXS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STXS Per share dataSTXS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2 0.3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as STXS's earnings are expected to grow with 25.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.04%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. STXS Dividend Analysis

5.1 Amount

  • STXS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

STXS Fundamentals: All Metrics, Ratios and Statistics

STEREOTAXIS INC

NYSEARCA:STXS (3/27/2026, 8:04:00 PM)

After market: 1.82 0 (0%)

1.82

-0.07 (-3.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-09
Earnings (Next)05-11
Inst Owners46.75%
Inst Owner Change0.5%
Ins Owners19.36%
Ins Owner Change5.15%
Market Cap177.00M
Revenue(TTM)32.38M
Net Income(TTM)-22.91M
Analysts81.82
Price Target4.28 (135.16%)
Short Float %4.76%
Short Ratio5.54
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.16%
Min EPS beat(2)-14.38%
Max EPS beat(2)10.06%
EPS beat(4)3
Avg EPS beat(4)6.4%
Min EPS beat(4)-14.38%
Max EPS beat(4)24.59%
EPS beat(8)4
Avg EPS beat(8)-10.64%
EPS beat(12)5
Avg EPS beat(12)-9.69%
EPS beat(16)7
Avg EPS beat(16)-8.22%
Revenue beat(2)0
Avg Revenue beat(2)-9.66%
Min Revenue beat(2)-12.63%
Max Revenue beat(2)-6.69%
Revenue beat(4)2
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-12.63%
Max Revenue beat(4)6.54%
Revenue beat(8)3
Avg Revenue beat(8)-1.01%
Revenue beat(12)4
Avg Revenue beat(12)-3.78%
Revenue beat(16)5
Avg Revenue beat(16)-5.06%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)8.84%
EPS NQ rev (3m)8.84%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-4.7%
Revenue NQ rev (3m)-4.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.47
P/FCF N/A
P/OCF N/A
P/B 9.45
P/tB 20.75
EV/EBITDA N/A
EPS(TTM)-0.25
EYN/A
EPS(NY)-0.19
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0.33
BVpS0.19
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -43.86%
ROE -122.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.73%
FCFM N/A
ROA(3y)-50.25%
ROA(5y)-41.46%
ROE(3y)-148.26%
ROE(5y)-107.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.03%
GM growth 5Y-5.84%
F-Score5
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.98%
Cap/Sales 0.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.09
Altman-Z -12.75
F-Score5
WACC10.63%
ROIC/WACCN/A
Cap/Depr(3y)23.67%
Cap/Depr(5y)379.44%
Cap/Sales(3y)0.59%
Cap/Sales(5y)2.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y22.81%
EPS Next 2Y25.04%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)20.28%
Revenue growth 3Y4.77%
Revenue growth 5Y3.99%
Sales Q2Q%36.31%
Revenue Next Year29.83%
Revenue Next 2Y32.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year91.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-61.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.06%
OCF growth 3YN/A
OCF growth 5YN/A

STEREOTAXIS INC / STXS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of STEREOTAXIS INC (STXS) stock?

ChartMill assigns a fundamental rating of 3 / 10 to STXS.


What is the valuation status of STEREOTAXIS INC (STXS) stock?

ChartMill assigns a valuation rating of 1 / 10 to STEREOTAXIS INC (STXS). This can be considered as Overvalued.


Can you provide the profitability details for STEREOTAXIS INC?

STEREOTAXIS INC (STXS) has a profitability rating of 0 / 10.


How financially healthy is STEREOTAXIS INC?

The financial health rating of STEREOTAXIS INC (STXS) is 5 / 10.